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Abstract
The relative roles of the endosomal TLR3/7/8 versus the intracellular RNA helicases RIG-I and MDA5 in viral infection is much
debated. We investigated the roles of each pattern recognition receptor in rhinovirus infection using primary bronchial
epithelial cells. TLR3 was constitutively expressed; however, RIG-I and MDA5 were inducible by 8–12 h following rhinovirus
infection. Bronchial epithelial tissue from normal volunteers challenged with rhinovirus in vivo exhibited low levels of RIG-I
and MDA5 that were increased at day 4 post infection. Inhibition of TLR3, RIG-I and MDA5 by siRNA reduced innate cytokine
mRNA, and increased rhinovirus replication. Inhibition of TLR3 and TRIF using siRNA reduced rhinovirus induced RNA
helicases. Furthermore, IFNAR1 deficient mice exhibited RIG-I and MDA5 induction early during RV1B infection in an
interferon independent manner. Hence anti-viral defense within bronchial epithelium requires co-ordinated recognition of
rhinovirus infection, initially via TLR3/TRIF and later via inducible RNA helicases.
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Introduction
Human rhinovirus (RV) belongs to the Picornaviridae family and
are implicated in an extensive range of human respiratory
disorders including the common cold, viral bronchiolitis, and
exacerbations of asthma and chronic obstructive pulmonary
disease [1–5]. RV are classified as major or minor group based
on receptor usage, or RNA identity as RV-A and RV-B. RVs of
both major and minor groups are associated with human disease.
Recently, this phylogeny been changed to include the newly
designated RV-C group which represent a distinct group of RV
[6]. RV of all groups generally infect the epithelial cells of both the
upper and lower airway, and are responsible for the induction of a
range of mediators including pro-inflammatory cytokines and
growth factors [7–11], type I interferon (IFN)-b and type III IFN-
ls [12]. Pro-inflammatory cytokines contribute to the duration
and severity of RV induced illnesses [13–16]. Recently, primary
human bronchial epithelial cells (HBECs) from asthmatics were
found to be defective in IFN-b and IFN-l mRNA and protein,
[17,18], providing a likely explanation for the increased vulner-
ability to virus induced asthma exacerbations and enhanced
symptom severity observed [16,19]. Understanding the mecha-
nisms responsible for these deficiencies in asthma, as well as
identifying new anti-inflammatory therapies requires a detailed
understanding of the innate reponses to RV infection.
Much is now known about the signal transduction pathways
utlised by viruses to induce cytokines and IFNs. RNA viruses are
initially sensed through pattern recognition receptors (PRRs), such
as recognition of dsRNA by endosomal Toll-like receptor (TLR)-3,
[20,21] or ssRNA by endosomal TLR7/8 [22,23]. TLR3 utilises
the adaptor TIR domain-containing adapter inducing IFN-b
(TRIF), to activate IkB kinase (IKK-i/e) and TANK binding
kinase-1 (TBK-1), and IKK-b activating interferon regulatory
factor (IRF)-3 and NF-kB, transcription factors required for IFN-b
gene expression. Within the intracellular compartment, exists a
second set of PRRs, the RNA helicases, including retinoic acid
inducible gene (RIG-I) [24], melanoma differentiation associated
gene-5 (MDA5) [25], and the inhibitory protein LGP2 [26,27].
The helicases signal via their caspase recruitment domains
(CARD), to adaptor inducing interferon-b (CARDIF) [28], (also
known as IPS-1, MAVS and VISA, [29–31]), and activate TBK1,
IKK-i/e and IKK-b, and hence IRF3 and NF-kB. Both RIG-I
and MDA5 have been implicated in IFN-a/b production in
various model systems. MDA5 recognises high molecular weight
dsRNA [32], while the specificity of RIG-I has been marked with
controversy. While originally identified as a dsRNA binding
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helicase [24], RIG-I has recently been shown to bind low
molecular weight dsRNA [32] and also 59-triphosphorylated
ssRNA [33,34]. The 59-triphosphorylated ssRNA binding prefer-
ences of RIG-I suggest it is unable to recognize Picornavirus
infections [33,35]; which do not synthesis 59-triphosphorylated
RNA molecules. The relative importance of TLR3, MDA5 or
RIG-I in viral infections has been partly defined by cells derived
from TLR32/2 [21], RIG-12/2 or MDA52/2 mice [35,36],
however the importance of each PRR, including their exclusive or
redundant roles in various infection models, and their direct
relevance to human disease remains a subject of much debate.
In order to understand the recognition of RV infection, and the
induction of both pro-inflammatory cytokines and IFNs, we
investigated the role of TLR3/7/8, RIG-I and MDA5 in the
innate response to RV infection in primary HBECs, the target cell
for RV infection within the lower airway in vivo. We found that
HBECs did not respond to the ligand R-848. Importantly, TLR3,
and RNA helicase mediated signaling was required for maximal
IFN-b, IFN-l and pro-inflammatory cytokine gene expression,
showing that RIG-I is required for anti-viral defense against
Picornaviruses. Furthermore, RIG-I and MDA5 were virus
inducible genes, induced early via a TLR3/TRIF pathway,
indicating that TLR3 acts as an initial endosomal sensor and must
induce the RNA helicases for maximal anti-viral defense during
the course of infection. Thus the innate response to RV infection
requires co-ordinated endosomal, and cytoplasmic recognition
pathways, both of which contribute to IFN and cytokine
production.
Results
Primary HBECs express TLR3, and RNA helicases RIG-I and
MDA5, which are RV inducible genes with similar
expression kinetics to RV induced IFN-b and IFN-l
We first sought to assess the relationship between TLR3/7/8,
and the RNA helicases in RV infection in bronchial epithelial cells.
Initial studies showed that HBECs encoded mRNA and protein
for TLR3, but did not induce IFN-b, IFN-l, RIG-I or MDA5
mRNA in response to the TLR7/8 ligand R848 (Table S1 in
Supporting Information S1), consistent with other studies showing
that lung bronchial epithelial, alveolar and airway smooth muscle
cells do not respond to TLR7/8 agonists [9,37,38]. The presence
and/or absence and virus induction of TLR3 and RNA helicases
was then investigated. Time course analysis in HBECs demon-
strated that IFN-b was induced by 8 h post infection, and 4 h for
IFN-ls post RV1B infection. IFN-b peaked at 12 h and remained
at high levels until 48 h, while the IFN-ls remained elevated from
12 h and peaked at 48 h (Figure 1A–C). In the same experiments,
RIG-I and MDA5 mRNA levels were also measured, and were
induced by RV1B by 8 h, peaked by 18 h post infection and
remained at high level until 48 h post infection (Figure 1D–E). At
the protein level, RIG-I and MDA5 protein were both observed by
8 h following RV1B infection, and showed maximal levels at 18–
24 h (Figure 1F). Uninfected cells and cells sampled at time 0 h
exhibited almost non-detectable expression of RIG-I and MDA5
protein, suggesting that in the absence of active infection, RIG-I
and MDA5 proteins are absent or expressed at very low level.
TLR3 protein however was present in both infected and
uninfected cells, and the levels did not change over the time
course of RV1B infection. Similar data was observed for TLR3
mRNA (data not shown). The cytoplasmic staining of RIG-I and
MDA5 were confirmed using immunofluorescence, with RV1B
and IFN-b inducing both RIG-I (Figure 1G upper panel) and MDA5
(Figure 1G lower panel) at 24 h post treatment in HBECs, compared
to cells treated with medium, or RV1B infected cells stained with a
secondary antibody only.
RIG-I and MDA5 are induced in columnar bronchial
epithelial cells upon experimental RV challenge in vivo
In order assess the baseline expression and the RV mediated
induction of RIG-I and MDA5 protein in bronchial epithelium in
vivo, bronchial biopsies were taken from 15 normal adult
volunteers before experimental RV16 infection (baseline) or at
day 4 post infection and stained for RIG-I and MDA5 by
immunohistochemistry. Representative staining of biopsy samples
are presented in Figure 2A–E. The degree of epithelial staining for
RIG-I and MDA5 protein were scored quantitatively, and
presented in Figure 2F. RIG-I (A) and MDA5 (C) had little
staining at baseline, and MDA5 was increased at day 4 post RV16
infection, (Figure 2D). Scoring of columnar epithelial staining (F)
showed that MDA5 at day 4 was significantly higher than baseline
(p,0.05), however RIG-I levels were not significantly different at
day 4 versus baseline (Figure 2B).
TLR3, RIG-I and MDA5 are required for maximal RV
induced IFN-b, and IFN-l
The PRRs involved in RV infection and induction of innate
responses are largely unknown. In order to assess the role of
TLR3, RIG-I and MDA5 in RV induced IFNs we used RNA
interference with specific small interfering RNA (siRNA) to
knockdown each PRR in HBECs in vitro, prior to RV infection.
Initial experiments demonstrated that siRNA generated .75%
knockdown of target mRNA at 24 h post treatment, and this
knockdown was evident until 48 h post treatment (data not
shown). Therefore, siRNA was delivered 24 h before infection,
and total RNA harvested 24 h post RV1B infection, giving a
total siRNA transfection time of 48 h. The knockdown of each
target mRNA was confirmed in each experiment, and
knockdown of target protein also confirmed at 48 h post
transfection (Figure 3A–H). Also, experiments were performed
Author Summary
Host-pathogen interactions are mediated by pattern
recognition receptors that identify conserved structures
of micro-organisms that are distinct from self. During a
viral infection, important pattern recognition receptors
include the endosomal Toll-like receptors (TLRs), and a
second set of cytoplasmic pattern recognition receptors
known as the RNA helicases. Many studies have highlight-
ed the importance of TLR3, TLR7/8 and the RNA helicases
in providing robust anti-viral immunity via interferon
induction and inflammation. Both endosomal TLR and
cytoplasmic RNA helicase mediated pathways are believed
to exist as separate yet non-redundant entities; however,
little thought is given to why both systems exist, and few
studies also consider how both pathways together
contribute to anti-viral immunity. Using models of
rhinovirus infection in primary bronchial epithelial cell
culture in vitro and experimental infection in mouse and
human models in vivo, we show that the RNA helicases are
preferentially induced early in the infection cycle via TLR3
mediated signaling events, and work in a co-ordinated,
systematic manner. The results help understand the
complex events that determine effective innate immunity
to rhinovirus infection and how these processes contribute
to virus induced exacerbations of asthma and chronic
obstructive pulmonary disease.
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in the absence of RV infection to examine the effects of siRNA
on endogenous IFN and pro-inflammatory cytokine gene
expression. Each siRNA did not significantly induce any of
the IFNs or pro-inflammatory cytokines studied (Table S2 & S3
in Supporting Information S1). Furthermore, RIG-I and MDA5
siRNA were highly specific, RIG-I siRNA did not affect
endogenous MDA5 gene expression, and MDA5 siRNA did
not affect endogenous RIG-I gene expression (data not shown).
TLR3, RIG-I and MDA5 siRNA all reduced RV1B induced
IFN-b compared to control siRNA (Figure 4A,D,G respective-
ly). In contrast, siRNA targeting RIG-I did not reduce IFN-l1
mRNA, (Figure 4E) however siRNA specific for TLR3 and
MDA5 reduced IFN-l1 (Figure 4B,H respectively). RIG-I
siRNA enhanced RV induced IFN-l2/3 mRNA (Figure 4F),
while both MDA5 and TLR3 reduced RV1B induced IFN-l2/3
(Figure 4C,I). These data suggest that TLR3, RIG-I and MDA5
are all required for IFN-b, and TLR3 and MDA5 for IFN-l,
however the importance of RIG-I in IFN-ls is less clear. To
confirm these findings, we next used siRNA specific for the
TLR3 adaptor TRIF, and the RNA helicase adaptor Cardif. We
found that RV1B induced IFN-b and IFN-l1 mRNA expression
was inhibited by both siRNA to TRIF and Cardif, while IFN-
l2/3 was inhibited by TRIF siRNA only compared to control
siRNA (Figure S1).
Figure 1. Kinetics of RV1B induced IFN-b, IFN-ls, RIG-I and MDA5 mRNA and protein expression in HBECs. HBECs were infected with
RV1B or treated with medium and RNA and protein analysed over time. RV1B induced IFN-b (A), IFN-l1 (B) and IFN-l2/3 mRNA (C) in a time
dependent manner, visible by 4 h, and peaking at 12–48 h. RV1B infection also induced RIG-I (D) and MDA5 mRNA (E), in a time dependent manner,
peaking at 18–48 h. RV1B infection also induced RIG-I and MDA5 protein (F) in a similar time dependent manner, visible by 8 h post infection by
western blotting. Medium treated cells exhibited little or no RIG-I or MDA5 protein during the timecourse. TLR3 protein levels were present in
medium treated cells, and did not change during the course of RV1B infection. Immunofluorescence identified both cytoplasmic RIG-I and MDA5 to
be induced after RV1B or IFN-b treatment at 24 h, compared to medium treated cells, or cells stained with secondary antibody only. Horizontal line
indicates 20 mm scale. Staining for both helicases was observed within the cytoplasm (in green, G). *p,0.05, **p,0.01, ***p,0.001, RV1B infected
versus medium treated cells. mRNA data was generated from 6 independent experiments utilizing 3 independent HBEC donors, 2 experiments per
donor.
doi:10.1371/journal.ppat.1001178.g001
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TLR3, RIG-I and MDA5 are required for maximal RV
induced pro-inflammatory cytokine gene expression
The role of TLR3, RIG-I and MDA5 on the T cell chemokines
rantes and IP-10, and the neutrophil chemokines IL-8 and ENA-
78 were also investigated. Figure 5 shows that TLR3, RIG-I and
MDA5 siRNA all reduced RV1B induced rantes compared to
control siRNA (Figure 5A,E,I). Likewise, TLR3, RIG-I and
MDA5 siRNA all reduced RV induced IP-10 (Figure 5B,F,J).
TLR3, RIG-1 and MDA5 siRNA also reduced RV induced IL-8
mRNA (Figure 5C,G,K). Finally TLR3, RIG-I and MDA5 siRNA
also reduced RV1B induced ENA-78 compared to control siRNA
(Figure 5D,H,L). In support of the above, siRNA specific for
Cardif and TRIF reduced all RV1B induced pro-inflammatory
cytokines compared to control siRNA (Figure S2).
Inhibition of RIG-I and MDA5 increased RV replication
As RIG-I and MDA5 were required for RV1B induced IFN-b
and both IFN-b and IFN-l gene expression respectively, we next
reasoned that their role was not redundant and that abrogation of
either RNA helicase would result in increased RV replication in
HBECs. Figure 6A demonstrates that after 24 h post infection,
RV16 RNA levels were increased after transfection with siRNA
specific for RIG-I compared to control siRNA. RV1B RNA levels
were also increased. Also, using siRNA specific for MDA5, an
increase in RV1B RNA was observed, compared to cells transfected
with control siRNA, and RV16 RNA levels were slightly increased
compared to control siRNA. In the same experiments, virus release
was also determined by titration assay, 48 h after infection. Figure 6B
demonstrates that transfection with RIG-I specific siRNA resulted in
increased RV16 release compared to control siRNA and slightly
increased RV1B virus release. Conversely, transfection with MDA5
specific siRNA resulted in higher RV1B release, and a small increase
in RV16 virus release compared to control siRNA. Furthermore,
transfection of the bronchial epithelial cell line BEAS-2B, with
dominant negative RIG-I (RIG-IC), resulted in enhanced replication
of RV16 RNA (Figure 6C), at 24 h and RV16 virus release at 48 h
post infection (Figure 6D). Transfection of constitutively active RIG-
I (DRIG-I) resulted in up to 60 fold suppression of RV1B and 47 fold
suppression of RV16 virus release at 48 h (Figure S3). This data
further implicates the RNA helicase RIG-I in RV recognition and
induction of anti-viral activity.
RV induced RIG-I and MDA5 gene expression involved
TLR3/TRIF signalling
As RV1B infection induced both early RIG-I and early
MDA5 protein and mRNA production, and both are required
Figure 2. RIG-I and MDA5 expression in bronchial biopsy tissue following in vivo RV16 infection. Normal individuals underwent fibre-
optic bronchoscopy at baseline or day 4 following RV16 challenge, and bronchial biopsies were taken, and assessed for RIG-I protein by
immunohistochemistry at baseline (A) and day 4 post RV16 challenge (B). Biopsies were also assessed for MDA5 protein at baseline (C) and day 4 post
RV16 challenge (D). Positive staining is indicated by the brown coloration, localized to the columnar epithelial cells. Background staining was assessed
by incubating a Day 4 biopsy with secondary antibody only (E). Staining scores of bronchial epithelium showing increases at day 4 compared to
baseline (F) *p,0.05 as indicated, NS = not significant. Scale is indicated by the horizontal bar.
doi:10.1371/journal.ppat.1001178.g002
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for maximal anti-rhinoviral activity, we sought to identify the
receptor(s) responsible for RNA helicase induction. As RV
enters via the endosome, we hypothesized that TLR3 was
responsible for increased RIG-I and MDA5 gene expression. In
order to investigate the relationship between TLR3/TRIF
signaling and RIG-I and MDA5 gene expression in RV
Figure 3. Effects of each siRNA on RIG-I, MDA5, TLR3 and TRIF mRNA and protein levels. HBECs were transfected with siRNA specific for
RIG-I or control siRNA, infected with RV1B and RIG-I protein (A) and mRNA (B) measured. HBECs were transfected with MDA5 specific siRNA or control
siRNA and infected with RV1B and MDA5 protein (C) and mRNA (D) measured. HBECs were transfected with siRNA specific for TLR3 or control siRNA
and infected with RV1B and TLR3 protein (E) and mRNA (F) measured. HBECs were transfected with siRNA specific for TRIF or control siRNA and
infected with RV1B and TRIF protein (G) and mRNA (H) measured. *p,0.05, **p,0.01, ***p,0.001 versus control siRNA or as indicated. mRNA data
was generated from 6 independent experiments utilizing 3 independent HBEC donors, 2 experiments per donor.
doi:10.1371/journal.ppat.1001178.g003
Figure 4. Role of TLR3, RIG-I and MDA5 in RV1B induced IFN-b, and IFN-l gene expression in HBECs. HBECs were transfected with
control siRNA or siRNA specific for TLR3 (A–C), RIG-I (D–F), MDA5 (G–I), and infected with RV1B. IFN-b (A,D,G), IFN-l1(B,E,H) and IFN-l2/3 (C,F,I) mRNA
were measured 24 h post infection **p,0.01, ***p,0.001 versus control siRNA, NS= not significant. mRNA data was generated from 6 independent
experiments utilizing 3 independent HBEC donors, 2 experiments per donor.
doi:10.1371/journal.ppat.1001178.g004
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infection, we next assessed if specific knockdown of TLR3 and
the adaptor TRIF affected RV1B induced RNA helicase gene
expression. Figure 7 demonstrates that siRNA specific for TLR3
reduced RV1B induced RIG-I mRNA versus control siRNA,
(Figure 7A), and reduced RV1B induced MDA5 mRNA
(Figure 7B). Consistent with the sequential affect of TLR3 on
RNA helicase induction, we found that RIG-I specific siRNA
did not affect TLR3 mRNA levels compared to control siRNA
(Figure 7C), and MDA5 specific siRNA also did not affect
TLR3 mRNA levels compared to control siRNA (Figure 7D).
Furthermore, siRNA specific for the TLR3 adaptor TRIF,
reduced RV1B induced RIG-I mRNA (Figure 7E) and also
RV1B induced MDA5 mRNA compared to control siRNA
(Figure 7F). In each experiment, knockdown of TRIF mRNA by
TRIF specific siRNA was confirmed, and we also confirmed
knockdown of TRIF protein at 48 h post transfection
(Figure 3G,H). Using a plasmid encoding constitutively active
TRIF (DTRIF), the reverse of the above results were obtained in
HBECs (Figure 7G,H). Transfection with DTRIF significantly
increased both RIG-I and MDA5 gene expression, compared to
empty vector control (pUNO1). Furthermore, incubation of
HBECs with the TLR3 ligand polyIC induced RIG-I mRNA
from 4–24 h post treatment (Figure 7I) and MDA5 from 8–24 h
(Figure 7J). PolyIC treatment also induced RIG-I and MDA5
protein by 4–12 h post treatment as shown by western blotting
(Figure 7K) and immunofluorescence (Figure 8A). Finally
siRNA specific for TLR3 or TRIF reduced polyIC induced
RIG-I and MDA5 protein (Figure 8B), strongly implicating
TLR3/TRIF mediated signal transduction in RV induced RNA
helicase induction in HBECs.
Figure 5. Role of TLR3, RIG-I and MDA5 in RV1B induced pro-inflammatory cytokine gene expression in HBECs. HBECs were
transfected with control siRNA or siRNA specific for TLR3 (A–D), RIG-I (E–H), MDA5 (I–L), and infected with RV1B. Rantes (A,E,I), IP-10 (B,F,J), IL-8 (C,G,K),
and ENA-78 (D,H,L) mRNA were measured 24 h post infection *p,0.05, **p,0.01, ***p,0.001 versus control siRNA. *p,0.05, **p,0.01, ***p,0.001
versus control siRNA or as indicated. mRNA data was generated from 6 independent experiments utilizing 3 independent HBEC donors, 2
experiments per donor.
doi:10.1371/journal.ppat.1001178.g005
Figure 6. Effects of RIG-I and MDA5 abrogation on RV
replication in HBECs. HBECs were transfected with siRNA specific
for RIG-I, MDA5 or control siRNA, infected with RV1B or RV16 and vRNA
determined by PCR at 24 h (A) or RV release by titration at 48 h (B).
BEAS-2B cells were transfected with 0.5 mg RIG-IC or pEF-BOS control,
and RV16 vRNA (C) and virus release (D) determined. mRNA data was
generated from 5 independent experiments utilizing 3 independent
HBEC donors, 2 experiments per donors 1,2 and a one experiment for
donor 3; and 4 independent experiments for BEAS-2B cells.
doi:10.1371/journal.ppat.1001178.g006
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RV1B infection in vivo resulted in initial increased RIG-I
and MDA5 expression in the absence of type I and type
III IFN signalling
As RV induced RIG-I and MDA5 occurred early, and in a
TLR3/TRIF dependent manner, and as the TLR3 and TRIF
pathway leads to IRF3 activation and IFN-b and IFN-l induction,
we assessed the role of IFN signalling in RV1B induced RIG-I and
MDA5. In our in vitro experiments with HBECs, it was difficult to
rule out the role of endogenous, or RV induced early IFN-b/l
inducing RIG-I and MDA5. We therefore ultilised IFNAR1
deficient mice, in a mouse model of RV1B infection [39]. IFNAR1
deficient mice are devoid of IFN-a/b signaling, and spleen cells
have recently been shown to have reduced IFN-l (IL-28B)
production in vitro and lack IFN-l within the vagina in vivo [40].
Figure 9 shows that following RV1B infection, IFNAR1 deficient
mice produced a low level of IFN-b within the lung but did not
produce IFN-l, however wildtype controls produce both IFN-b
mRNA at 24 h (Figure 9A) and IFN-l mRNA at 48 h (Figure 9B).
At 8 h post infection, RV1B infection of IFNAR1 deficient mice
and wildtype mice both resulted in increased RIG-I (Figure 9C)
and MDA5 gene expression compared to time 0 h, (Figure 9D).
The induction of RIG-I and MDA5 was biphasic for both IFNAR1
deficient and wildtype mice, wildtype mice produced higher levels
of RIG-I and MDA5 mRNA at 16 h post infection, and at 48 h
post infection for RIG-I only. Cytoplasmic protein from lung
homogenates were extracted and probed for RIG-I and MDA5
protein by western blotting. Both IFNAR12/2 and wildtype mice
exhibited increased RIG-I and MDA5 protein at 8 h compared to
mock infected controls. At later time points (24 h and 48 h)
wildtype mice had more RIG-I and MDA5 protein compared to
IFNAR1 deficient mice, likely caused by IFN signaling (blots are
shown in Figure 9E and densitometry compared to a-tubulin
shown in Figure 9F&G). This data therefore shows that initial RV
induced RIG-I and MDA5 is IFN independent, and that at later
time points, further virus replication increases in RIG-I and
MDA5 gene expression later on in IFNAR12/2 mice, and in
wildtypes further virus replication and IFN signaling events
contribute to later lung RNA helicase mRNA expression.
Discussion
Viral dsRNA and ssRNA are recognised by at least two
independent pattern recognition pathways, composed of TLR3,
and TLR7/8 in the endosome and the RNA helicases RIG-I,
MDA5 in the cytoplasm. Previous studies have employed well
established models of virus infection, however similar studies using
viruses important to human disease in their natural host cell type in
vivo are largely yet to be performed. In the present study, we describe
the role of TLR3 and RNA helicases in the recognition of RV
infection in primary HBECs, the main cell type infected in the lower
respiratory tract in vivo. RV is an important human pathogen,
responsible for a range of illnesses including asthma exacerbations.
We have used both major group RV16 and minor group RV1B
(approximately 77% genome identity) in our studies, as both these
groups represent the majority of RVs involved in human disease.
Understanding the basis of RV recognition and signalling leading to
IFN and pro-inflammatory cytokines could potentially lead to new
therapeutic targets for RV associated illnesses.
We found that TLR3, RIG-I and MDA5 were required for
IFN-b while MDA5 and TLR3 were required for maximal IFN-
Figure 7. Role of TLR3 and TRIF in RV1B induced RIG-I and MDA5 expression. HBECs were transfected with siRNA specific for TLR3 or
control siRNA (A,B) RIG-I or control siRNA (C) or MDA5 or control siRNA (D), TRIF or control siRNA (E,F) infected with RV1B, and RIG-1 (A,E), MDA5 (B,F)
or TLR3 mRNA (C,D) measured at 24 h. HBECs were transfected with DTRIF or pUNO1 plasmids, or were left untransfected, and RIG-I (G) and MDA5
mRNA (H) measured 24 h post transfection. HBECs were treated with the TLR3 ligand polyIC or medium and RIG-I (I) and MDA5 mRNA (J) measured at
various time points, or RIG-I and MDA5 protein assessed by western blotting over time (K). *p,0.05, **p,0.01, ***p,0.001 versus control siRNA,
pUNO1, or medium treated cells, NS = not significant. mRNA data was generated from 5 independent experiments utilizing 3 independent HBEC
donors, 2 experiments per donors 1,2 one experiment for donor 3.
doi:10.1371/journal.ppat.1001178.g007
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l1 and IFN-l2/3 mRNA expression. We then hypothesized that
the most likely explanation for the dual requirement of both
endosomal and cytoplasmic recognition systems and the impor-
tance of both RIG-I and MDA5 for IFN-b expression was that the
endosomal and cytoplasmic recognition pathways were in some
way linked, and their sequential activation was required for
maximal IFN-b and IFN-l gene expression. This is in contrast to
other studies, which have observed mostly cell type specific
differences concerning RIG-I/MDA5 and the TLR family
members, with murine embryonic fibroblasts (MEFs) and
conventional dendtitic cells (DCs) utilizing RIG-I and MDA5 for
virus induced IFN production [25,36] while plasmacytoid DCs use
TLRs including TLR3 [35,36]. Despite these findings, a recent
study has reported the induction of type I IFN after i.p. injection of
polyIC, to be reduced in TRIF2/2 and IPS-12/2 double deficient
mice, compared to either IPS2/2 or TRIF2/2 mice [41]. A
number of recent in vitro studies have also reported a role for both
TLR and RNA helicase signalling in polyIC induced responses,
[42–45]. In short, explanations for differences between these
results are likely due to cell type dependence on one pattern
recognition system versus another, and the models of virus
infection employed. We argue that for structural cells, including
epithelial cells at mucosal surfaces, these cells may have evolved a
dual dependency on both endosomal and intracellular recognition
systems, which may be dissimilar for leukocytes including DCs.
Hence as a first line defense against viral infection, efficient IFN
production is an outcome of both TLR and RNA helicase
mediated signalling working together.
The siRNA experiments we performed have demonstrated the
requirement of TLR3 and MDA5 for IFN-ls, but TLR3, RIG-I
and MDA5 for IFN-b gene expression. TLR3, RIG-I and MDA5
were also all important for a range of pro-inflammatory
cytokines, including T cell chemokines rantes and IP-10 and
neutrophil chemokines IL-8 and ENA-78. These results confirm
and expand on recent data by Wang et al [46], using BEAS-2B
cells and specific siRNA transfection, Wang et al showed that
MDA5, TRIF but not RIG-I was important for RV induced IFN-
b, IFN-ls and several interferon stimulated genes (ISGs). The
role of MDA5 was confirmed in primary tracheobronchial
epithelial cells. However why or how MDA5 and TLR3 are
both required for RV infection in these studies was not analyzed
in any depth. Our observation of RIG-I being important for IFN-
b in HBECs could be due differences between BEAS-2B cells and
HBECs, or differences in efficiency of siRNA knockdown of
target mRNA. Our data also show that the RIG-IC DN also
increases RV replication in BEAS-2B cells, again suggests a role
for RIG-I in RV responses. Why RIG-I was not required for
IFN-l expression in our studies is unclear. Possible explanations
for these results could be that MDA5 siRNA was more consistent
at reducing the target mRNA compared to RIG-I siRNA, or that
at the time point studied (24 h), MDA5 is more important than
RIG-I in IFN-l expression. IFN-b and the IFN-ls are both IRF3
responsive [47], and it is possible that for RV infection, MDA5 is
more efficiently activated, resulting in robust signalling and IRF3
activation. Recently, it has been shown that IRF3 activation is
complex, requiring multiple kinases for maximal phosphorylation
and activation [48]. It is possible that differences exist between
RIG-I and MDA5 signaling to IRF3, or IFN-b and IFN-l
promoters have different requirements for IRF3 activation. It has
also previously been observed that siRNA transfection can
interfere with endogenous RNA sensing molecules [49,50] and
induce spontaneous IFN or cytokine production. All our siRNA
were used to minimize potential off-target effects; they were used
as pools of four individual siRNAs, and were designed with
minimal known stimulatory sequences and also contained 39 UU
overhangs to minimize activation of RIG-I, which can be
activated by siRNA [49]. We were careful to assess the likelihood
of spontaneous induction of IFN or cytokines studied by all
siRNA, and we did not observe significant induction for control
or any specific siRNA. Therefore, we are confident that our
results using siRNA are accurately describing the role of each
molecule in RV dependent responses, and are not confounded
due to siRNA recognition by endogenous processes or are the
result of obvious off-target effects.
Initial experiments into the specificity of RIG-I suggested it
bound in vitro transcribed and/or 59-triphosphorylated ssRNA
[33–35], and therefore could not recognize the RNA of
picornaviruses such as encephalomyocarditis virus (EMCV) which
do not synthesize 59-triphosphosphorylated ssRNA. This has been
questioned recently with the observation that RIG-I can bind low
weight dsRNA [32]. Other than EMCV, little is known about the
role of RIG-I in the infection of Picornaviruses. Our data provide
definitive evidence that both RIG-I and MDA5 are important in
innate responses to RV infection. Knockdown of both RIG-I and
MDA5 produced higher viral loads of major group RV16 and
minor group RV1B, again providing evidence that RIG-I can
recognize the RNA of Picornaviruses. As the 7kB RV genome
replicates in a RNA dependent manner, we argue that dsRNA
molecules are present during replication in the cytoplasm. Hence,
it is plausible that dsRNA of differing sizes could potentially ligate
both RNA helicases. Future studies to confirm these interactions,
such as immunoprecipitation studies are necessary to investigate
the exact nature of the RNA species that RIG-I and MDA5 are
binding to in the context of RV infection in HBECs.
Figure 8. Role of TLR3 and TRIF in polyIC induced RIG-I and MDA5 protein. HBECs were treated with polyIC or medium and examined using
immunofluorescence at 24 h for RIG-I (upper panel, A) and MDA5 (lower panel, A). Both cytoplasmic RIG-I and MDA5 (in green) was induced after
polyIC treatment at 24 h, compared to medium treated cells, or cells stained with secondary antibody only. Horizontal line indicates 20 mm scale.
HBECs were treated with polyIC or medium for 8 h and the effects of TLR3 and TRIF siRNA on polyIC induced RIG-I and MDA5 assessed by western
blotting (B). TLR3 and TRIF siRNA reduced RIG-I and MDA5 protein compared to control siRNA. a-tubulin was used to control for protein loading.
doi:10.1371/journal.ppat.1001178.g008
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Having established that TLR3, RIG-I and MDA5 were all
required for innate responses and that RIG-I and MDA5 protein
was not constitutively expressed in HBECs, whereas TLR3 was
constitutively expressed, we hypothesized that RIG-I and MDA5
could be induced by TLR3 activation. While we did not study the
early events of viral entry, RV has been used as a model
Picornavirus and their biology has been extensively studied. RV
enters via the endosome where the acidified environment is
essential to viral uncoating and release of +ve sense ssRNA.
[51,52]. Despite being a ssRNA virus, the 7kB ssRNA genome
contains some secondary structures [53,54], including the 59
multiple stem loop structure, containing the ribosome entry site,
which has been previously visualized in endosomes during virus
uncoating [55]. As RV infection requires the formation of mature
endosomes, and contains dsRNA structures, thus our results could
be explained by TLR3 sensing these events during viral entry; and
initiate signaling leading to IFN, and RIG-I and MDA5 gene
expression during the first few hours of infection. Further
Figure 9. Expression of RIG-I and MDA5mRNA and protein in wildtype and IFNAR1 deficient mice.Wildtype 129/SvJ and IFNAR12/2mice
were infected with RV1B and lung protein and mRNA analysed over time. In wildtype mice, and to a lesser extent, IFNAR12/2mice, RV1B induced IFN-
b mRNA (A), and IFN-lmRNA only in wildtype mice (B), and induced RIG-I in both wildtype and IFNAR12/2 mice (C). RV1B also induced MDA5 in both
wildtype and IFNAR12/2 mice (D). In both wildtype and IFNAR12/2 mice, RIG-I and MDA5 mRNA induction was evident by 8 h post infection. RV1B
also induced RIG-I and MDA5 protein by 8 h in both wildtype and IFNAR12/2 mice, measured by western blot (E), and RIG-I and MDA5 protein as a
ratio of a-tubulin protein measured by densitometry over time is also shown (F&G respectively) *p,0.05, **p,0.01 ***p,0.001 versus time 0 h or as
indicated.
doi:10.1371/journal.ppat.1001178.g009
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experiments are required to prove or disprove this idea however.
HBECs were unresponsive to the TLR7/8 ligand R848, strongly
suggesting this cell type lacks these TLRs, and that TLR3 rather
than TLR7/8 is involved in RIG-I and MDA5 induction. TLR3
has previously been implicated in RV recognition in BEAS-2B
cells [56] and HBECs [9]. Interestingly, unlike BEAS-2B cells, we
found that TLR3 was not virus inducible in undifferentiated
HBECs. In both models however, TLR3 is constitutively
expressed, enforcing the hypothesis that TLR3 is an initial sensor
of viral nucleic acid in this cell type.
A range of experiments in HBECs demonstrated that RIG-I/
MDA5 induction was TLR3/TRIF dependent. Very recently, co-
operation between RIG-I/MDA5 and TLR3 has been suggested
in a murine model of coxsackievirus infection [57]. TLR3 was
absolutely required for defense against coxsackievirus infection, by
inducing IFN-c. The authors suggest that TLR3 mediated
induction by IFN-c may work in parallel with RIG-I/MDA5
inducing type I IFN, and further suggested that these responses
may be coupled, although potential mechanisms for this were not
explored. We believe however that our study is the first to provide
definitive evidence of endosomal and intracellular PRRs working
in concert. We argue that as RV enters via endosomes, yet most of
the dsRNA load occurs in the cytoplasm, the idea of two related
pattern recognition systems seem plausible. RV replicates in the
cytoplasm, and produces multiple centers of RNA dependent
RNA replication, therefore increases in the RNA helicases can be
viewed as a mechanism to continually monitor the intracellular
RNA load (likely dsRNA and ssRNA), and through RNA
helicases, induce IFN and cytokines consistently, during the course
of infection. The upregulation of IFN-b, IFN-l and T cell and
neutrophil cytokines are highly important for the control of virus
replication and acute inflammatory responses within the airway
(for a summary, see Figure S4). It would be extremely interesting
to study other common human respiratory viruses which
preferentially infect bronchial epithelial cells, or viruses that infect
other mucosal surfaces such as the gut, to investigate if maximal
IFN and cytokine responses require both TLR3, and RIG-I/
MDA5.
Finally, we assessed the role of IFN-a/b signaling in RIG-I and
MDA5 induction. RIG-I and MDA5 are ISGs, a consistent
observation in many different cell types and models [24,57–60].
We have also observed that in HBECs, RIG-I and MDA5 are
IFN-b and IFN-l inducible (data not shown). As RIG-I and
MDA5 are IFN inducible, our in vitro experiments could not rule
out the possibility of the effects of low level IFN inducing RIG-I
and MDA5. Our data in vivo, however clearly show that RIG-I and
MDA5 can be induced in the absence of IFN-b and IFN-l,
IFNAR12/2 mice, which cannot respond to type I IFN and are
unable to produce IFN-l in the lung, still produced RIG-I and
MDA5 mRNA and protein upon RV1B infection. Also, in HBECs
with intact IFN responses, RIG-I/MDA5 mRNA was upregulated
early, by 4–8 h, and we argue this quick response is likely IFN
independent.
We believe this is the first report of sequential involvement or
collaboration of TLR and RNA helicase mediated pathways for
innate defense against a virus infection. Our overall model is
depicted in Figure S4. The model argues that RIG-I and MDA5
that are not well expressed in uninfected cells are both virus
inducible via the constitutively expressed TLR3/TRIF, and later
IFN inducible. Upon RV infection, TLR3 signaling in the
endosome gives quick induction of new RIG-I and MDA5.
Importantly, the model highlights the need for RNA helicase
induction to be quick, in a few hours in infected cells. After several
hours, as virus moves out of the endosome and into the cytoplasm,
newly synthesized virus RNA is sensed by RIG-I/MDA5. This is
where the majority of viral nucleic acid will be for the rest of the
infection cycle, and is likely key in the induction of innate immune
response to RV infection. At later time points, the actions of IFN-b
and IFN-ls may further induce RIG-I and MDA5 in infected and
non-infected cells. In non-infected cells, the presence of IFN may
‘‘warn’’ neighboring cells about the presence of viruses, and
prepare the epithelium through upregulation of interferon
inducible genes including RIG-I and MDA5.
Our initial interest in PRRs important in RV infection and IFN
expression came from studies in asthmatic individuals which
showed bronchial epithelial cells from asthmatics had very low
levels of IFN-b and IFN-l expression and increased RV
replication compared to non-asthmatic controls [17,18]. It is
currently believed that IFN-b, or IFN-ls could contribute to the
outcome of asthma exacerbations. While these studies implicate
the bronchial epithelium as a key producer of IFN-b and IFN-ls in
RV infections, it is unclear which IFN is more important in
protection. Understanding the regulation of both type I and type
III IFNs is therefore a research goal for identifying why asthmatics
have deficient innate responses to RV infection. The results of the
present study have identified the importance of RIG-I, MDA5 and
TLR3 in RV induced IFN, therefore future studies should
scrutinize these pathways in asthmatics and non-asthmatics to
ascertain if asthmatics have defective signaling leading to
decreased IFN production.
In summary we provide evidence that the dsRNA receptor
TLR3 acts to induce both RIG-I and MDA5 gene and protein
expression in HBECs in a model of RV infection. Both RIG-I and
MDA5 were required for maximal IFN and pro-inflammatory
cytokine induction, and control of RV replication indicating that
they have non-redundant roles in RV infection. The data support
a model that in HBECs, TLR3 but not TLR7/8 operate in
concert with RIG-I/MDA5, and are together required for innate
responses to RV infection. As asthmatic HBECs have reduced RV
inducible IFN-b and IFN-l expression compared to non-asthmatic
cells, both the TLR3 and RNA helicase pathways warrant further




HBECs from non-asthmatic, non-smoking individuals were
obtained from a commercial source (Clonetics, Wokingham, UK),
and cultured in BEGM with supplements according to the
suppliers recommended protocol (Clonetics). Unless otherwise
stated, all data was derived from experiments from 3 different
HBEC sources. BEAS-2B cells (European Collection of Cell
Cultures) were cultured in RPMI with 10% FCS (Invitrogen,
Paisley, UK). HeLa cells were grown in DMEM with 10% FCS
(Invitrogen), and used for RV titration assays. Major group RV16
and minor group RV1B were grown in HeLa cells, after three
cycles of freeze and thawing, supernatant and cellular material
where clarified by centrifugation at 4,000 rpm for 15 min, filter
sterilized, aliquoted and frozen at -80uC. The serotype of all RV
stocks was confirmed by titration with serotype specific anti-sera
(American Type Culture Collection), and all RV stocks and cells
were confirmed to be free of Mycoplasma contamination using a
commercially available detection kit (Roche, Burgess Hill, UK).
Transient transfections with siRNA or plasmid DNA
HBECs were cultured to 80% confluency in 12 well plates and
transfected with 100 nM specific siRNA or control siRNA (specific
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for luciferase, Dharmacon, Lafayette, CO, USA), for 24 h prior to
infection with RV1B. Time courses and dose responses of siRNA
were performed previously to determine optimum conditions for
knockdown of target genes. All siRNA achieved at least a 75%
knockdown of target mRNA, and each siRNA was assessed for the
induction of IFN or pro-inflammatory cytokine mRNA in the
absence of infection. HBECs were cultured to near confluency in
12 well plates and then transfected with 0.25 mg per well of
DTRIF-pUNO1 (a constitutive active TRIF cDNA, Invivogen,
San Diego CA, USA), or pUNO1 control plasmid (Invivogen) or
left untransfected for 5 h. All transfections were with Lipofecta-
mine 2000 (Qiagen, Crawley, UK) according to the manufacturers
recommended protocol. Complexes were removed, medium
replaced and cells left for 24 h. RNA was then extracted and
RIG-I, MDA5 mRNA measured. DRIG-I, RIG-IC and pEF-BOS
control vector [24] were used to transfect BEAS-2B cells, at 0.25–
0.5 mg per well, using Superfect (Qiagen) according to the
manufacturer’s recommended protocol.
Infection of HBECs and BEAS-2B cells
HBECs were cultured to 80% confluency in 12 well plates,
using BEGM (Clonetics) and starved in BEBM (no supplements)
overnight and infected with RV1B for 1 h with shaking at room
temperature, and samples taken at appropriate time points.
Alternatively, HBECs were transfected with siRNA (Dharmacon),
placed in BEGM without serum and then infected with RV1B.
BEAS-2B cells were placed in 2% FCS containing RPMI medium
overnight and infected with RV1B or RV16 for 1 h as above and
placed in 2% FCS containing RPMI medium until required. For
experiments involving enumerating virus replication, adhered
virus was washed off by three additions of medium after the 1 h
infection period.
RNA extraction, cDNA synthesis and quantitative PCR
Total RNA was extracted from HBECs (RNeasy kit, Qiagen),
and 2 mg was used for cDNA synthesis (Omniscript RT kit,
Qiagen). Total RNA was also extracted from the upper left lobe of
the mouse lung, and placed in RNA later (Qiagen), prior to RNA
extraction and cDNA synthesis (as above). Quantitative PCR was
carried out using specific primers and probes for each gene (Table
S4 in Supporting Information S1). Reactions consisted of 12.5 ml
of 2X Quanti-Tect Probe PCR Master Mix (Qiagen) in 25 mL.
cDNA for 18S amplifications were diluted 1/100 in sterile water.
Reactions were analyzed using an ABI 7000 TaqMan, (ABI Foster
City, CA, USA) at 50uC for 2 min, 94uC for 10 min, and 45 cycles
of 94uC for 15 s and 60uC for 15 s. Each gene was normalized to
18S rRNA, and for HBEC studies, presented as copies of each
mRNA per 26105 cells, and for mouse lung, per cDNA reaction
using a standard curve based on amplification with plasmid DNA.
For siRNA experiments, copy number was expressed as a % of
copy number versus control siRNA.
SDS PAGE, Western blotting and immunofluorescence
For western blotting, total protein lysates were run on 4–12%
Bis-Tris polyacrylamide gels, and transferred onto nitrocellulose
membranes (Invitrogen), blocked in 5% skim milk, and probed
with antibodies specific for mouse and human RIG-I (Cell
Signaling, Danvers, MA, USA), diluted to 0.083 mg/mL, MDA5
1 mg/mL (Santa Cruz Biotechnology Inc, CA, USA), a-tubulin
0.2 mg/mL (Santa Cruz Biotechnology Inc), or b-actin, 1 mg/mL
(Biovision, Mountain View CA, USA). Secondary antibodies used
were goat anti-mouse HRP, 0.08 mg/mL, sheep anti-rabbit HRP,
2 mg/mL (AbD Serotec, Oxford, UK) and swine anti-goat HRP
1.4 mg/mL (Invitrogen). Blots were developed using ECL (GE
Healthcare, Chalfont St Giles, UK). For immunohistochemistry,
HBECs were grown on 8 well chamber slides (Nunc, Rochester
NY, USA), infected with RV or treated with 10 ng/mL IFN-b,
5 mg/mL polyIC or medium for 8 or 24 h, and washed with PBS,
fixed in 4% paraformaldehyde at room temperature for 5–7 min,
washed once with PBS, and permeabilized with 0.2% Triton X-
100 for 5 min at room temperature, and washed again in PBS.
Slides were then blocked with a 1% BSA, 10% FCS-PBS
overnight at 4uC. Cells were then stained with either anti-RIG-I,
2 mg/mL (Santa Cruz Biotechnology, Inc) or anti-MDA5, 2.7 mg/
mL (Santa Cruz Biotechnology Inc) for 1 h at room temperature.
Slides were washed three times with PBS, and stained with for 1 h
at room temperature with donkey anti-goat Alexa Fluor 488,
6.7 mg/mL, and washed as above. Slides were then mounted with
4,6-diamidino-2-phenyindole dilactate containing mounting me-
dium, and analysed using a colour CCD camera microscope
(Zeiss, Rugby, UK).
Analysis of human bronchial epithelium from individuals
challenged with RV16 in vivo
Paraffin embedded bronchial biopsies were obtained from 15
non-asthmatic non-smoking individuals used in a previous in vivo
challenge study with RV16 [16]. Samples were coded, and
analyzed blind according to infection status, for RIG-I and MDA5
prior to infection (baseline) or at day 4 after infection. Goat
antibodies to RIG-1 and MDA5 (Santa Cruz Biotechnology, Inc)
at 2 mg/mL and 1 mg/mL were used respectively. Swine anti-goat
LSAM-HRP reagents (DakoCytomation, Ely, UK), were used as
per the manufacturer’s recommended protocol, and antibody
binding visualized using perioxidase staining. Staining intensity on
surface epithelium was scored accordingly as 0–3, with no staining
scored as 0 and intense staining scored as 3.
Infection of IFNAR1 deficient and wildtype mice with
RV1B
Female IFNAR12/2 and 129/SvJ control mice aged 6–9 weeks
were inoculated intranasally with 56106 TCID50 of RV1B,
essentially as previously described [39], and culled humanely by
lethal injection at various time points.
Ethics statement
The human experimental challenge study was approved by St
Mary’s NHS Trust. All volunteers gave informed, written consent.
All animal work was in accordance with Project License PPL70/
6387, and performed according to regulations outlined by the
Home Office, UK, in agreement with the Animals (Scientific
Procedures) Act 1986.
Statistical analysis
All in vitro experiments were performed 5–6 times, Figures 1, 3–
7 used 3 independent HBEC donors, and data generated in the
supporting information file also utilized 3 independent HBEC
donors. For siRNA experiments, data from each independent
experiment was converted to a % of the control siRNA + RV data,
and mean 6 SEM generated. All other data were expressed as
mean 6 SEM. Experiments using siRNA or transfection with
plasmids were analyzed by one ANOVA and Bonferroni’s
multiple comparison test, and time course data using two-way
ANOVA and Bonferroni’s multiple comparison test, using
GraphPad Prism software with p,0.05 taken as significant. For
differences between two groups, a student’s t-test was employed
with p,0.05 taken as significant. Experiments in the mouse model
involved 3–4 animals per group, in two independent experiments,
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(total of 6–8 animals) data were analyzed using two-way ANOVA
and Bonferroni’s multiple comparison test in GraphPad Prism.
Staining of human bronchial epithelium for RIG-I and MDA5
was analyzed by using the paired Mann-Whitney U test, p,0.05
taken as significant.
Supporting Information
Supporting Information S1 Tables S1 to S4.
Found at: doi:10.1371/journal.ppat.1001178.s001 (0.09 MB
DOC)
Figure S1 Role of TRIF and Cardif in RV1B induced IFN gene
expression in HBECs. (A) siRNA specific to TRIF and Cardif
reduced RV1B induced IFN-b compared to control siRNA at 24h
post infection. (B) siRNA specific to TRIF and Cardif reduced
RV1B induced IFN-l1 compared to control siRNA at 24h post
infection. (C) siRNA specific to TRIF reduced RV1B induced
IFN-l2/3 compared to control siRNA however siRNA specific to
Cardiff did not significantly reduce RV1B induced IFN-l2/3 at
24h post infection. *p,0.05, ***p,0.001 versus control siRNA +
RV1B, NS=not significant versus control siRNA+RV1B, n= 5
independent experiments, from 3 different HBEC donors, 2
experiments per donors 1,2 and one experiment for donor 3.
Found at: doi:10.1371/journal.ppat.1001178.s002 (10.10 MB
TIF)
Figure S2 Role of TRIF and Cardif in RV1B induced pro-
inflammatory cytokine gene expression in HBECs. (A) siRNA
specific to TRIF and Cardif reduced RV1B induced rantes
compared to control siRNA at 24h post infection. (B) siRNA
specific to TRIF and Cardif reduced RV1B induced IP-10
compared to control siRNA at 24h post infection. (C) siRNA
specific to TRIF and Cardif reduced RV1B induced IL-8
compared to control siRNA at 24h post infection. (D) siRNA
specific to TRIF and Cardif reduced RV1B induced ENA-78
compared to control siRNA at 24h post infection. ***p,0.001
versus control siRNA+RV1B, NS = not significant versus control
siRNA + RV1B, n= 5 independent experiments, from 3 different
HBEC donors, 2 experiments per donors 1,2 and one experiment
per donor 3.
Found at: doi:10.1371/journal.ppat.1001178.s003 (0.23 MB TIF)
Figure S3 RIG-I mediates the anti-viral responses in RV
infection in BEAS-2B cells. (A). Constitutively active RIG-I,
(DRIG-I) suppressed RV16 vRNA compared to pEF-BOS control
at 24h post infection. (B). DRIG-I suppressed RV16 release
compared to pEF-BOS control at 48h post infection. (C). DRIG-I
suppressed RV1B vRNA compared to pEF-BOS control at 24h
post infection. (D). DRIG-I suppressed RV16 release compared to
pEF-BOS control at 48h post infection. *p,0.05, **p,0.01,
***p,0.001 as indicated n= 4-6 independent experiments.
Found at: doi:10.1371/journal.ppat.1001178.s004 (0.21 MB TIF)
Figure S4 Proposed model of sequential involvement of TLR3/
TRIF and RIG-I/MDA5 in RV infecton. TLR3 and TRIF
initially are involved in RV signalling in the recognition of RV
infection and signal transduction within the endosome, and induce
IFN-b, IFN-l and RIG-I and MDA5 early with the infection cycle
(4-12h). After 12h, increases in RIG-I and MDA5 protein in the
intracellular compartment recognise a concominant increase in
intracellular RV dsRNA and ssRNA. This process induces robust
IFN-b and IFN-l and possibly further RIG-I and MDA5 gene
expression.
Found at: doi:10.1371/journal.ppat.1001178.s005 (6.49 MB
TIF)
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